Last updated: 30 August 2021 at 3:49pm EST

Raymond Townsend Net Worth




The estimated Net Worth of Raymond Townsend is at least $271 ezer dollars as of 25 September 2018. Raymond Townsend owns over 3,000 units of Kindred Biosciences Inc stock worth over $230,584 and over the last 11 years Raymond sold KIN stock worth over $39,960.

Raymond Townsend KIN stock SEC Form 4 insiders trading

Raymond has made over 13 trades of the Kindred Biosciences Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Raymond sold 3,000 units of KIN stock worth $39,960 on 25 September 2018.

The largest trade Raymond's ever made was exercising 17,561 units of Kindred Biosciences Inc stock on 2 January 2018 worth over $60,585. On average, Raymond trades about 2,338 units every 83 days since 2013. As of 25 September 2018 Raymond still owns at least 24,928 units of Kindred Biosciences Inc stock.

You can see the complete history of Raymond Townsend stock trades at the bottom of the page.



What's Raymond Townsend's mailing address?

Raymond's mailing address filed with the SEC is C/O KINDRED BIOSCIENCES, INC., 1555 BAYSHORE HIGHWAY, SUITE 200, BURLINGAME, CA, 94010.

Insiders trading at Kindred Biosciences Inc

Over the last 11 years, insiders at Kindred Biosciences Inc have traded over $10,542,886 worth of Kindred Biosciences Inc stock and bought 50,952,388 units worth $461,948,778 . The most active insiders traders include Animal Health Inc Elanco, West Asset Management Llc Park és Ernest Mario. On average, Kindred Biosciences Inc executives and independent directors trade stock every 34 days with the average trade being worth of $5,949,674. The most recent stock trade was executed by Animal Health Inc Elanco on 27 August 2021, trading 45,508,938 units of KIN stock currently worth $420,957,677.



What does Kindred Biosciences Inc do?

Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company’s strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.



What does Kindred Biosciences Inc's logo look like?

Kindred Biosciences Inc logo

Complete history of Raymond Townsend stock trades at Kindred Biosciences Inc

Dátum
#
Cég
Az érdekelt
Trans.
Tranzakció
Részvények száma Ár per részvény Teljes ár Részvények szíma után Forrás
25 Sep 2018 Raymond Townsend
Rendező
Eladás 3,000 $13.32 $39,960
25 Sep 2018
24,928
15 Mar 2018 Raymond Townsend
Rendező
Opció Gyakorlat 7,301 $3.45 $25,188
15 Mar 2018
27,928
12 Mar 2018 Raymond Townsend
Rendező
Opció Gyakorlat 246 $3.45 $849
12 Mar 2018
23,297
2 Jan 2018 Raymond Townsend
Rendező
Opció Gyakorlat 17,561 $3.45 $60,585
2 Jan 2018
23,142
23 Nov 2015 Raymond Townsend
Rendező
Megvenni 2,000 $4.00 $8,000
23 Nov 2015
12,000
23 Nov 2015 Raymond Townsend
Rendező
Megvenni 2,000 $4.00 $8,000
23 Nov 2015
12,000
18 Nov 2015 Raymond Townsend
Rendező
Megvenni 2,323 $4.78 $11,104
18 Nov 2015
10,000
18 Nov 2015 Raymond Townsend
Rendező
Megvenni 2,323 $4.78 $11,104
18 Nov 2015
10,000
31 Aug 2015 Raymond Townsend
Rendező
Megvenni 1,677 $5.85 $9,810
31 Aug 2015
7,677
31 Aug 2015 Raymond Townsend
Rendező
Megvenni 1,677 $5.85 $9,810
31 Aug 2015
7,677
14 Aug 2015 Raymond Townsend
Rendező
Megvenni 3,000 $6.04 $18,120
14 Aug 2015
6,000
14 Aug 2015 Raymond Townsend
Rendező
Megvenni 3,000 $6.04 $18,120
14 Aug 2015
6,000
11 Dec 2013 Raymond Townsend
Rendező
Megvenni 3,000 $7.00 $21,000
11 Dec 2013
3,000


Kindred Biosciences Inc executives and stock owners

Kindred Biosciences Inc executives and other stock owners filed with the SEC include: